Industries: Healthtech & Medtech, Biotech & Pharma, Wellness & Beauty
Technologies: Artificial Intelligence, Big Data Other fields: -
Funding stage: Founded: 2018 Employees:
Business model: Marketplace, Subscription Target: Business, Consumer
Irritable Bowel Syndrome (IBS) is a chronic condition that affects 15% of the population. Diet, lifestyle changes and probiotics can help improve IBS symptomatology, but they need to be carefully tailored to each individual case. ALVUM Microbiota uses artificial neural networks (ANN) to find patterns in lifestyle, Bristol Stool Form Scale (BSFS) and gut microbiota data. ANN results are transformed into personalised diet and supplement recommendation based on the latest medical research.
We are continually updating our list of new startups so please let us know if you have recently started one.